ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2026
A generalized approach for estimating the Pace of Aging.
Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundQuantifying the rate of aging is essential for understanding age-related physiological decline and predicting late-life outcomes. The Pace of Aging (PoA) framework addresses this by modeling longitudinal changes across multiple biomarkers. However, the original Dunedin PoA assigns equal weight to all biomarkers and was derived from a young cohort with limited mortality follow-up, which restricts its applicability in older populations and in settings where biomarker relevance is uncertain.
methodsWe developed a weighted Pace of Aging (wPoA) using data from the Swedish Adoption/Twin Study of Aging (SATSA), a longitudinal cohort of older adults with up to nine waves of biomarker data collected over three decades. Using mixed-effects models, we estimated individual random intercepts and slopes for 10 biomarkers and assigned weights to these random effects based on their association with time-to-mortality. This mortality-informed weighting distinguishes the wPoA from the original Dunedin PoA.
resultsWe found that wPoA was positively correlated with established biological age predictors and more strongly correlated with low-dimensional predictors such as the Functional Aging Index (FAA) and the Frailty Index (FI). Modest correlations across all considered predictors suggest that each measure captures distinct aspects of biological aging.
conclusionsIn conclusion, the wPoA framework introduces a data-driven weighting of random effects and is particularly well-suited for aging cohorts and in settings where marker relevance is uncertain a priori, such as high-dimensional or omics-based contexts. This work provides a foundation for future single-timepoint surrogates that can also be used in settings lacking rich longitudinal data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.